GLP-1 medicines such as semaglutide and tirzepatide are changing how we treat diabetes and obesity. But their impact may eventually extend much further because they change appetite. And when medicines change appetite, they inevitably change food consumption and the choices people make about food. New research from International Flavors & Fragrances, presented at the company’s…
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
